PANoptosis: a potential target of cardiomyopathy. [PDF]
Sun M, Lu C, Wei J, Gao C, Dong D.
europepmc +1 more source
Interplay of oxidative stress and Inflammasome activation and clinical indices in Parkinson's disease: insights from serum SIRT1, Nrf2, and NLRP3 levels and PDQ-39-a cross-sectional study. [PDF]
Aldossary KM +10 more
europepmc +1 more source
Conservation of NLRP3 Inflammasome Pathway in Monotremes and Large-Scale Restructuring of the Caspase-1 Gene Cluster Region in Mammals. [PDF]
Stevens D, Daish T, Grützner F.
europepmc +1 more source
Downregulation of Cathepsin B expression alleviates periodontitis by reducing mitochondrial reactive oxygen species production and NOD-, LRR-, and pyrin domain-containing 3 -mediated pyroptosis. [PDF]
Wang T +8 more
europepmc +1 more source
Targeting pyroptosis to treat aortic aneurysms: From mechanism to drug discovery (Review). [PDF]
Mao J, Luo M, Ruan L, Zhang C.
europepmc +1 more source
Celastrol alleviates esophageal stricture in rats by inhibiting NLR family pyrin domain containing 3 activation. [PDF]
Zhang MX +7 more
europepmc +1 more source
Serum RAC1 as a potential biomarker in the early stages of diabetic kidney disease. [PDF]
Fang Y +9 more
europepmc +1 more source
The role of pyroptosis in ovarian cancer. [PDF]
Zhou Y, Peng T, Zhang J, Liang R.
europepmc +1 more source
Peroxiredoxin 1 inhibits tumorigenesis by activating the NLR family pyrin domain containing 3/gasdermin D pathway: Advanced therapies targeting heterogeneous cell death mechanisms. [PDF]
Smirnova A +4 more
europepmc +1 more source
Peroxiredoxin 1, pyroptosis, and the emerging frontier in colorectal cancer therapy. [PDF]
Maurya DK.
europepmc +1 more source

